2017-09-13 12:27:22 UTC

RFP Issued to Identify Best Practices in IBD Shared-Decision Making

Sept. 13, 2017

Applications accepted from Sept. 11 through Oct. 13

AGA and the Crohn’s & Colitis Foundation (Foundation), in collaboration with Pfizer, Inc., have released a request for proposal (RFP) around interventions that aim to improve shared decision-making and promote effective health communication between inflammatory bowel disease (IBD) patients and their clinicians. The goal is to identify and/or establish best practices around shared decision-making that can be easily replicated, broadly disseminated and widely adopted within the IBD community. 

Applicants are encouraged to design programs or initiatives that explore or address gaps in communication in areas ranging from lifestyle and social issues to challenges related to determining treatment options. 

The RFP is open from Sept. 11 through Oct. 13, 2017; awardees will be determined by Nov. 22. Using an expert panel, AGA, the Foundation and Pfizer will select two projects for funding by December 2017. The projects will be fully funded from 2018 through 2019 in the amount of $500,000 each, over two years. 

Learn more about the grant and how to apply. 

More on IBD

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.